BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27655694)

  • 1. Smyd2 is a Myc-regulated gene critical for MLL-AF9 induced leukemogenesis.
    Bagislar S; Sabò A; Kress TR; Doni M; Nicoli P; Campaner S; Amati B
    Oncotarget; 2016 Oct; 7(41):66398-66415. PubMed ID: 27655694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia.
    Chen L; Sun Y; Wang J; Jiang H; Muntean AG
    Oncotarget; 2016 May; 7(18):25208-23. PubMed ID: 27007052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
    Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias.
    Young K; Loberg MA; Eudy E; Schwartz LS; Mujica KD; Trowbridge JJ
    Exp Hematol; 2020 Sep; 89():61-67.e3. PubMed ID: 32768438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of MLL-AF9, MLL and MYC expression is not obligatory for monocyte-macrophage maturation in AML-M5 cell lines carrying t(9;11)(p22;q23).
    Martino V; Tonelli R; Montemurro L; Franzoni M; Marino F; Fazzina R; Pession A
    Oncol Rep; 2006 Jan; 15(1):207-11. PubMed ID: 16328057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model.
    Liu Q; Chen L; Atkinson JM; Claxton DF; Wang HG
    Cell Death Dis; 2016 Sep; 7(9):e2361. PubMed ID: 27607576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of the Shb gene in mixed-lineage leukemia MLL-AF9 cells increases latency in mice despite higher proliferation rates in vitro.
    Jamalpour M; Bergquist E; Welsh M
    Exp Cell Res; 2020 Dec; 397(2):112368. PubMed ID: 33220260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ets1 Plays a Critical Role in MLL/EB1-Mediated Leukemic Transformation in a Mouse Bone Marrow Transplantation Model.
    Fu JF; Yen TH; Huang YJ; Shih LY
    Neoplasia; 2019 May; 21(5):469-481. PubMed ID: 30974389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia.
    Zhang J; Seet CS; Sun C; Li J; You D; Volk A; Breslin P; Li X; Wei W; Qian Z; Zeleznik-Le NJ; Zhang Z; Zhang J
    Mol Oncol; 2013 Dec; 7(6):1069-82. PubMed ID: 23988911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein.
    Jenkins CE; Shevchuk OO; Giambra V; Lam SH; Carboni JM; Gottardis MM; Holzenberger M; Pollak M; Humphries RK; Weng AP
    Exp Hematol; 2012 Sep; 40(9):715-723.e6. PubMed ID: 22613471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of disease progression in MLL-rearranged AML.
    Kotani S; Yoda A; Kon A; Kataoka K; Ochi Y; Shiozawa Y; Hirsch C; Takeda J; Ueno H; Yoshizato T; Yoshida K; Nakagawa MM; Nannya Y; Kakiuchi N; Yamauchi T; Aoki K; Shiraishi Y; Miyano S; Maeda T; Maciejewski JP; Takaori-Kondo A; Ogawa S; Makishima H
    Leukemia; 2019 Mar; 33(3):612-624. PubMed ID: 30209403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapy.
    Haladyna JN; Pastuer T; Riedel SS; Perraud AL; Bernt KM
    Exp Hematol; 2016 Jul; 44(7):596-602.e3. PubMed ID: 27033163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lysine methyltransferase SMYD2 is required for normal lymphocyte development and survival of hematopoietic leukemias.
    Brown MA; Edwards MA; Alshiraihi I; Geng H; Dekker JD; Tucker HO
    Genes Immun; 2020 Feb; 21(2):119-130. PubMed ID: 32115575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
    Luo RT; Lavau C; Du C; Simone F; Polak PE; Kawamata S; Thirman MJ
    Mol Cell Biol; 2001 Aug; 21(16):5678-87. PubMed ID: 11463848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model.
    Bergerson RJ; Collier LS; Sarver AL; Been RA; Lugthart S; Diers MD; Zuber J; Rappaport AR; Nixon MJ; Silverstein KA; Fan D; Lamblin AF; Wolff L; Kersey JH; Delwel R; Lowe SW; O'Sullivan MG; Kogan SC; Adams DJ; Largaespada DA
    Blood; 2012 May; 119(19):4512-23. PubMed ID: 22427200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis.
    Tan J; Jones M; Koseki H; Nakayama M; Muntean AG; Maillard I; Hess JL
    Cancer Cell; 2011 Nov; 20(5):563-75. PubMed ID: 22094252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human MLL-AF9 Overexpression Induces Aberrant Hematopoietic Expansion in Zebrafish.
    Tan J; Zhao L; Wang G; Li T; Li D; Xu Q; Chen X; Shang Z; Wang J; Zhou J
    Biomed Res Int; 2018; 2018():6705842. PubMed ID: 30003105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.
    Pattabiraman DR; McGirr C; Shakhbazov K; Barbier V; Krishnan K; Mukhopadhyay P; Hawthorne P; Trezise A; Ding J; Grimmond SM; Papathanasiou P; Alexander WS; Perkins AC; Levesque JP; Winkler IG; Gonda TJ
    Blood; 2014 Apr; 123(17):2682-90. PubMed ID: 24596419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
    Wang Z; Medrzycki M; Bunting ST; Bunting KD
    Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential requirement for wild-type Flt3 in leukemia initiation among mouse models of human leukemia.
    Kamezaki K; Luchsinger LL; Snoeck HW
    Exp Hematol; 2014 Mar; 42(3):192-203.e1. PubMed ID: 24269847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.